Lyell Immunopharma, Inc. (LYEL) Net margin 2019–2025
Lyell Immunopharma, Inc. (LYEL) net profit margin by fiscal year — reported net income divided by reported revenue.
-762355.6%FY2025 · since FY2019: -19692.1% → -762355.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -762355.6% | -200070.3 pp |
| FY2024 | -562285.2% | -381799.1 pp |
| FY2023 | -180486.2% | -180269.9 pp |
| FY2022 | -216.2% | +2133.2 pp |
| FY2021 | -2349.5% | +286.8 pp |
| FY2020 | -2636.3% | +17055.8 pp |
| FY2019 | -19692.1% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice